Steven Cohen Pfizer Inc Call Options Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $6.54 Million - $7.41 Million	-236,200 Reduced 27.94%	609,300 $17.6 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $1.03 Million - $1.21 Million	-40,900 Reduced 4.61%	845,500 $23.7 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $22.9 Million - $26.4 Million	886,400 New	886,400 $24.6 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $9.53 Million - $11.2 Million	-300,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $9.04 Million - $11 Million	300,000 New	300,000 $9.81 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.